About
Biomedical Bonding AB (BMB) is a Swedish MedTech company focused on developing advanced medical adhesives and surgical methodologies for hard tissue repair, particularly in bone fracture surgery and dental restorations. The company aims to provide alternatives to traditional metal implants, addressing unmet clinical needs with innovative solutions. BMB's core innovation is the Bonevolent™ technology platform, which features a unique category of adhesive resin-composites designed for biocompatibility and high mechanical strength. This platform allows for the creation of customizable composite-based fixators tailored to individual patient needs, enhancing recovery outcomes and the healing process. Key products include the Bonevolent™ AdhFix, a customizable implant system for fracture fixation. The company collaborates with clinical partners and research institutions to validate its technology and is committed to becoming a leading provider of adhesive products in the fracture fixation and dental restoration markets. BMB is headquartered in Stockholm, Sweden, and is led by CEO Evelina Mikaelson and Chief Medical Officer Rami Elias, emphasizing its strong clinical focus.
Technologies
Keywords
Company Information
-
Employees 7
-
Founded 2008
Location
38a Teknikringen, Stockholm, Stockholm County, Sweden, 114 28
